Subscribe for unlimited access to DynaMed content, CME/CE & MOC credit, and email alerts on content you follow.
Already subscribed? Sign in now
Phenotype | Lipoproteins(s) Elevated | Serum Cholesterol Level | Serum Triglyceride Level | Atherogenicity |
---|---|---|---|---|
I | Chylomicrons | Normal to mildly increased | Very severely increased | None |
IIa | LDL | Moderately increased | Normal | Severe |
IIb | LDL and VLDL | Moderately increased | Moderately increased | Severe |
III | IDL | Moderately increased | Severely increased | Severe |
IV | VLDL | Normal to mildly increased | Moderately increased | Mild to Moderate |
V | VLDL and chylomicrons | Normal to mildly increased | Very severely increased | Mild to Moderate |
Abbreviations: HDL, high-density lipoprotein; IDL, * HDL cholesterol levels not considered. Reference - |
Topic Editors define the scope and focus of each topic by formulating a set of clinical questions and suggesting important guidelines, clinical trials, and other data to be addressed within each topic. Topic Editors also serve as consultants for the internal DynaMed Editorial Team during the writing and editing process, and review the final topic drafts prior to publication. |
Section Editors have similar responsibilities to Topic Editors but have a broader role that includes the review of multiple topics, oversight of Topic Editors, and systematic surveillance of the medical literature. |
Recommendations Editors provide explicit review of DynaMed Overview and Recommendations sections to ensure that all recommendations are sound, supported, and evidence-based. This process is described in "Synthesized Recommendation Grading." |
Deputy Editors are employees of DynaMed and oversee DynaMed internal publishing groups. Each is responsible for all content published within that group, including supervising topic development at all stages of the writing and editing process, final review of all topics prior to publication, and direction of an internal team. |
National Library of Medicine, or "Vancouver style" (International Committee of Medical Journal Editors):
Overview and Recommendations
Background
Evaluation
Management
Related Summaries
General Information
Description
Also called
Types
Epidemiology
Incidence/Prevalence
Likely risk factors
Possible risk factors
Associated conditions
Etiology and Pathogenesis
Causes
Pathogenesis
History and Physical
Diagnosis
Making the diagnosis
Differential diagnosis
Testing overview
Blood tests
Lipid profile
LDL cholesterol calculation
Other lipid parameters
Non-lipid blood tests
Management
Management overview
Recommendations including risk assessment
American College of Cardiology/American Heart Association (ACC/AHA) 2018 guidelines
European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) 2016 guidelines
National Institute for Care Excellence (NICE) 2014 guidelines (United Kingdom)
Choosing Wisely recommendations
Other risk assessment tools
Diet
Activity
Counseling
Medications
General information
Statins
Niacin
Prescribing information
Efficacy for cardiovascular disease risk reduction
Ezetimibe
Prescribing information
Efficacy overview (ezetimibe)
Efficacy for clinical outcomes
Efficacy for carotid artery intima-media thickness
Efficacy for improving dyslipidemia
Adverse events (ezetimibe)
PCSK9 inhibitors
General information
Evolocumab
Alirocumab
Bococizumab
Inclisiran
Bile acid-binding resins
ATP citrate lyase inhibitors
Herbs and dietary supplements
Surgery and procedures
Consultation and referral
Combination of lifestyle interventions
Follow-up
Complications and Prognosis
Prognosis
Prevention and Screening
Screening
Quality Improvement
Choosing Wisely
Choosing Wisely Australia
Physician Quality Reporting System Quality Measures
Guidelines and Resources
Guidelines
Guideline comparison
United States guidelines
United Kingdom guidelines
Canadian guidelines
European guidelines
Asian guidelines
Australian and New Zealand guidelines
African guidelines
Review articles
MEDLINE search
Patient Information
ICD Codes
ICD-10 codes
References
General references used
Recommendation grading systems used
Synthesized Recommendation Grading System for DynaMed
DynaMed Editorial Process
Special acknowledgements
How to cite
Adult and Pediatric Obesity Medicine Physician, Massachusetts General Hospital; Massachusetts, United States
Dr. Stanford declares no relevant financial conflicts of interest.
Director of Bahrain Branch of the United Kingdom Cochrane Center, The Cochrane Collaboration; Awali, Bahrain
Dr. Fedorowicz declares no relevant financial conflicts of interest.
Editor in Chief, DynaMed; Cardiologist, Beth Israel Deaconess Medical Center; Massachusetts, United States; Associate Professor of Medicine, Harvard Medical School; Massachusetts, United States
Dr. Oettgen declares no relevant financial conflicts of interest.
top